Healthcare Today

United Kingdom

https://healthcaretoday.com/

An independent voice delivering essential news, features, interviews, and expert insights for medical professionals.

followers

133

publications

2024

since

October 2026

September 24, 2026

Rare diseases affect approximately 3.5 million people in the UK, a patient cohort equivalent to the national cancer population, yet one where only 5% of conditions have approved treatments. Beyond the human impact, recent MHRA estimates place the combined healthcare and wider economic cost of rare diseases to the UK at nearly £19.6 billion a year. Combined with the rising global threat of antimicrobial resistance, the imperative for targeted healthcare delivery has never been higher. In this issue, LifeArc chief executive Sam Barrell breaks down why rare is not rare, how LifeArc is deploying £40 million into national rare disease trial acceleration centres, and what the UK must do to cement its position as a global life sciences hub. Also, Stablepharma CEO Özgür Tuncer talks about vaccine wastage; OCL Vision’s head of optometry Purvi Thomson explains how community optometrists can deliver accessible front-line services. and much more...

September 2026

August 27, 2026

For EQL co-founder and chief medical officer Peter Grinsbergs, closing the inequality gap requires a fundamental rethink of how patients enter the healthcare system. This month, he talks to Healthcare Today about taking clinical cues from professional sport, dismantling digital exclusion in deprived communities and why modern healthcare cannot afford to leave patients waiting while letters sit in the post. Also in this issue, Christoph Lippuner, co-founder and chief executive of Semble, examines how technology is empowering the era of self-health; Kamya Elawadhi, co-founder and president of Doceree explains why real-time intelligence at the point of prescribing is important; and much more...

August 2026

July 30, 2026

For Kirsten Detrick - adjunct professor of business administration at Tuck and Basel Area Life Sciences Supercluster representative in the US - successfully launching a breakthrough therapy in Europe is no longer a simple matter of clearing regulatory hurdles. It demands a fundamental strategic evolution, moving away from isolated functional silos and towards an integrated geographic ecosystem. In this issue, Kirsten talks about the strategic importance of building a centralised European presence. Also this month, Mass General Brigham Healthcare at Home’s Shiv Sutaria discusses the “win-win-win” of the post-pandemic virtual ward boom; Ian Adams, the current director of corporate affairs at NHS Resolution, reflects on how NHS Resolution became a more influential voice in patient safety; and much more...

July 2026

June 25, 2026

“The underlying economic system has changed, and the old way is no longer sustainable.” For Heitham Hassoun, the expansion of healthcare into global markets is not merely a strategic business play; it is a response to an irreversible shift in the global economic landscape. Here, the chief executive of Cedars-Sinai International talks about the alphabet soup of state-regulated systems, the necessity of building modern railroads for medical data, and why the most successful healthcare delivery must be built on trust and local relationships rather than just a famous brand name. Also in this issue, Danielle Brightman, clinical director of Numan, argues that a poorly regulated peptide market will put people in danger; Frances Lucraft, chief executive of Grace & Green, writes that mothers are dehydrating themselves to avoid bladder leaks; and much more...

June 2026

May 27, 2026

For Thomas Kelly, co-founder and chief executive of healthcare AI platform Heidi, the administrative burden of modern medicine isn’t just a productivity killer, it’s a clinical risk. Having spent years in the trenches as a vascular surgeon, he has seen the invisible shift that occurs when a doctor’s focus is split between the patient in front of them and the mountain of documentation that follows. In this issue, Kelly talks about clinical workflows, the regulatory double standard facing the industry, and why the future of clinical AI might actually be a wearable device on a surgeon’s chest. Also in this issue, Paola Barbarino, outgoing chief executive of Alzheimer’s Disease International, talks about the double whammy facing the sandwich generation; Motics chief executive Harvinder Power discusses the necessity of predictable machine learning; and much more...